Merete L Hetland Selected Research

Adalimumab (Humira)

1/2022	Assessment of immunogenicity and drug activity in patient sera by flow-induced dispersion analysis.
1/2020	Whole-Body Magnetic Resonance Imaging Assessment of Joint Inflammation in Rheumatoid Arthritis-Agreement With Ultrasonography and Clinical Evaluation.
1/2018	Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Merete L Hetland Research Topics

Disease

30	Rheumatoid Arthritis 10/2023 - 07/2008
8	Pain (Aches) 04/2024 - 01/2010
5	Psoriatic Arthritis 04/2024 - 01/2022
5	Inflammation (Inflammations) 01/2022 - 07/2008
4	Fatigue 04/2024 - 01/2010
4	Synovitis 10/2017 - 10/2010
3	Axial Spondyloarthritis 10/2022 - 01/2017
3	Arthritis (Polyarthritis) 01/2022 - 07/2008
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2017
2	Edema (Dropsy) 01/2017 - 08/2011
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Infections 01/2020
1	Necrosis 01/2018
1	Tenosynovitis 10/2017
1	Ankylosing Spondylitis 01/2017
1	Non-Radiographic Axial Spondyloarthritis 01/2017
1	Premature Birth (Birth, Premature) 12/2014
1	Drug-Related Side Effects and Adverse Reactions 07/2013

Drug/Important Bio-Agent (IBA)

9	Tumor Necrosis Factor InhibitorsIBA 04/2024 - 01/2017
6	ametantrone (HAQ)IBA 04/2024 - 01/2010
6	Antirheumatic Agents (DMARD)IBA 12/2019 - 10/2010
5	C-Reactive ProteinIBA 01/2022 - 10/2014
4	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 10/2010
3	Adalimumab (Humira)FDA Link 01/2022 - 01/2018
3	Rituximab (Mabthera)FDA Link 01/2020 - 02/2016
3	Anti-Citrullinated Protein AntibodiesIBA 09/2018 - 10/2010
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 01/2017
2	Abatacept (Orencia)FDA Link 01/2020 - 12/2019
2	Hormones (Hormone)IBA 12/2019 - 01/2019
2	Infliximab (Remicade)FDA Link 12/2019 - 07/2013
2	EnzymesIBA 12/2019 - 01/2019
2	GlucocorticoidsIBA 01/2017 - 07/2012
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 07/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2012 - 01/2012
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	secukinumabIBA 01/2022
1	MucinsIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	CholesterolIBA 11/2020
1	Triglycerides (Triacylglycerol)IBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	InflammasomesIBA 01/2020
1	Certolizumab Pegol FDA Link 12/2019
1	Biosimilar PharmaceuticalsIBA 12/2019
1	1,25-dihydroxyvitamin DIBA 09/2018
1	VitaminsIBA 09/2018
1	Vitamin D FDA LinkGeneric 09/2018
1	Circulating MicroRNAIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Galectin 3 (LGALS3)IBA 01/2017
1	ORALIT (ORS)IBA 12/2014
1	AutoantibodiesIBA 10/2014
1	FicolinsIBA 12/2013
1	AntibodiesIBA 07/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	Carrier Proteins (Binding Protein)IBA 01/2012
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2012
1	Immunoglobulin M (IgM)IBA 08/2011
1	Rheumatoid FactorIBA 08/2011
1	cyclic citrullinated peptideIBA 08/2011
1	Aligeron (AS 2)IBA 08/2011
1	Cartilage Oligomeric Matrix ProteinIBA 08/2011
1	AntigensIBA 06/2011
1	ChitinasesIBA 06/2011
1	Betamethasone (Celestone)FDA Link 10/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2008
1	Interleukin-6 (Interleukin 6)IBA 07/2008

Therapy/Procedure

8	Therapeutics 10/2023 - 10/2010
1	Aftercare (After-Treatment) 01/2020
1	Retreatment 01/2017
1	Intra-Articular Injections 10/2010